Publications and Presentations

 
 
CITATION STATISTICS
 
Total number of citations: 921
 
Average citations per year (since 2006): 102.33
 
h-index [?]: 15
 
i10-index [?]: 18
 
The above citation report is obtained from Google Scholar Citations.
 
 
 
Click here to view the geographic locations for publications that have cited my work.
 
 
 
 
 
 
 
 
 
 
 
 

PEER-REVIEWED PUBLICATIONS

  • Daneshmand S, Ahmadi H, Schuckman AK, Mitra AP, Cai J, Miranda G, Djaladat H. Enhanced recovery after surgery in patients undergoing radical cystectomy for bladder cancer. J Urol (in press). [PubMed]
  • Jayaratna IS, Mitra AP, Schwartz RL, Dorff TB, Schuckman AK. Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the western United States. Clin Genitourin Cancer 12(2):138-142, 2014. [PubMed]
  • Ross AE, Feng FY, Ghadessi M, Erho N, Crisan A, Buerki C, Sundi D, Mitra AP, Vergara IA, Thompson DJ, Triche TJ, Davicioni E, Bergstralh EJ, Jenkins RB, Karnes RJ, Schaeffer EM. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer Prostatic Dis 17(1):64-69, 2014. [PubMed]
  • Mitra AP, Bartsch CC, Bartsch G Jr, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol 32(2):117-127, 2014. [PubMed] [Citing articles]
  • Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients. Urol Oncol 32(1):52.e1-52.e9, 2014. [PubMed] [Citing articles]
  • Zehnder P, Moltzahn F, Daneshmand S, Leahy M, Cai J, Miranda G, Bartsch G Jr, Mitra AP, Skinner DG, Skinner EC, Gill IS. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy. BJU Int 113(1):65-69, 2014. [PubMed]
  • Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: Oncological outcomes. Int J Urol 20(12):1229-1233, 2013. [PubMed]
  • Karnes RJ, Bergstralh EJ, Davicioni E, Ghadessi M, Buerki C, Mitra AP, Crisan A, Erho N, Vergara IA, Lam LL, Carlson R, Thompson DJS, Haddad Z, Zimmermann B, Sierocinski T, Triche TJ, Kollmeyer T, Ballman KV, Black PC, Klee GG, Jenkins RB. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol 190(6):2047-2053, 2013. [PubMed] [Citing articles]
  • Birkhahn M, Mitra AP, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. Eur J Cancer 49(15):3159-3168, 2013. (Editorial feature) [PubMed] [Citing articles]
  • Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhäuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int 112(2):E51-E58, 2013. [PubMed] [Citing articles]
  • Erho N, Crisan A, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche TJ, Black PC, Karnes RJ, Klee G, Davicioni E, Jenkins RB. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One 8(6):e66855, 2013. [PubMed] [Citing articles]
  • Badani K, Thompson DJ, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra AP, Wood PJ, Hornberger J. Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group. Oncotarget 4(4):600-609, 2013. [PubMed] [Citing articles]
  • Ahmadi H, Mitra AP, Abdelsayed GA, Cai J, Djaladat H, Bruins HM, Daneshmand S. Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer. BJU Int 111(4b):E167-E172, 2013. [PubMed] [Citing articles]
  • Bruins HM, Wopat R, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. BJU Int 111(3b):E37-E42, 2013. [PubMed] [Citing articles]
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program. Cancer 119(4):756-765, 2013. (Cancer/ACS feature press release) (Editorial comment) [PubMed] [Citing articles]
  • Mitra AP, Skinner EC, Miranda G, Daneshmand S. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. BJU Int 111(2):240-248, 2013. [PubMed] [Citing articles]
  • Mitra AP, Hansel DE, Cote RJ. Prognostic value of cell-cycle regulation biomarkers in bladder cancer. Semin Oncol 39(5):524-533, 2012. [PubMed] [Citing articles]
  • Mitra AP, Jordà M, Cote RJ. Pathological possibilities and pitfalls in detecting aggressive bladder cancer. Curr Opin Urol 22(5):397-404, 2012. [PubMed]
  • Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int 109(6):846-854, 2012. [PubMed] [Citing articles]
  • Mitra SA, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. Front Genet 3:17, 2012. [PubMed] [Citing articles]
  • Mitra AP, Cote RJ. Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales? Expert Rev Anticancer Ther 11(6):849-852, 2011. (Cover feature) [PubMed]
  • Kapur P, Lotan Y, King E, Kabbani W, Mitra AP,  Mosbah A, Abol-Enein H, Ghoniem M, Youssef RF. Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers. Am J Clin Pathol 135(6):822-830, 2011. [PubMed] [Citing articles]
  • Bartsch G, Mitra AP, Cote RJ. Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10(12):1945-1954, 2010. (Cover feature) [PubMed] [Citing articles]
  • Mitra AP, Cote RJ. Molecular screening for bladder cancer: progress and potential. Nature Rev Urol 7(1):11-20, 2010. [PubMed] [Citing articles]
  • Birkhahn M, Mitra AP, Williams AJ, Lam G, Ye W, Datar RH, Balic M, Groshen S, Steven KE, Cote RJ. Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. Eur Urol 57(1):12-20, 2010. (Platinum priority) [PubMed] [Citing articles]
  • Mitra AP, Bartsch CC, Cote RJ. Strategies for molecular expression profiling in bladder cancer. Cancer Metastasis Rev 28(3-4):317-326, 2009. [PubMed] [Citing articles]
  • Mitra AP, Pagliarulo V, Yang D, Waldman FM, Datar RH, Skinner DG, Groshen S, Cote RJ. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. J Clin Oncol 27(24):3929-3937, 2009. [PubMed] [Citing articles]
  • Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol 4:251-285, 2009. [PubMed] [Citing articles]
  • Youssef RF, Mitra AP, Bartsch G Jr, Jones PA, Skinner DG, Cote RJ. Molecular targets and targeted therapies in bladder cancer management. World J Urol 27(1):9-20, 2009. [PubMed] [Citing articles]
  • Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 10(1):31-43, 2008. (Cover feature) [PubMed] [Citing articles]
  • Birkhahn M, Mitra AP, Cote RJ. Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev Anticancer Ther 7(12):1717-1727, 2007. (Cover feature) [PubMed] [Citing articles]
  • Mitra AP, Birkhahn M, Cote RJ. p53 and retinoblastoma pathways in bladder cancer. World J Urol 25(6):563-571, 2007. [PubMed] [Citing articles]
  • Mitra AP, Cote RJ. Searching for novel therapeutics and targets: insights from clinical trials. Urol Oncol 25(4):341-343, 2007. [PubMed] [Citing articles]
  • Mitra AP, Datar RH, Cote RJ. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24(35):5552-5564, 2006. (Cover feature) [PubMed] [Citing articles]
  • Mitra AP, Lin H, Datar RH, Cote RJ. Molecular biology of bladder cancer: prognostic and clinical implications. Clin Genitourin Cancer 5(1):67-77, 2006. (Cover feature) [PubMed] [Citing articles]
  • Mitra AP, Almal AA, George B, Fry DW, Lenehan PF, Pagliarulo V, Cote RJ, Datar RH, Worzel WP. The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer 6:159, 2006. (Highly accessed) [PubMed] [Citing articles]
  • Mitra AP, Lin H, Cote RJ, Datar RH. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management. Natl Med J India 18(6):304-312, 2005. [PubMed] [Citing articles]
  • Mitra AP, Datar RH, Cote RJ. Molecular staging of bladder cancer. BJU Int 96(1):7-12, 2005. [PubMed] [Citing articles]
 
 

 
 
 

 
 
 
 

PEER-REVIEWED ONLINE ARTICLES

  • Mitra AP, Birkhahn M, Penson DF, Cote RJ. Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder. In: Canellos GP, Schnipper L (editors). UpToDate. Waltham, MA: UpToDate; 2009-present. www.UpToDate.com
 
 

BOOK CHAPTERS

  • Mitra AP, Theodorescu D, Lerner SP, Cote RJ, Datar RH. Molecular biology and prognostic markers in bladder cancer. In: Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, Sheinfeld J, Rini BI, Bochner BH (editors). Comprehensive Textbook of Genitourinary Oncology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011. p. 317-333. ISBN 978-1-6083-1352-5 [Book information]
  • Cote RJ, Mitra AP, Amin MB. Bladder and urethra. In: Weidner N, Cote RJ, Suster S, Weiss LM (editors). Modern Surgical Pathology, 2nd ed. Philadelphia, PA: Saunders; 2009. p. 1079-1120. ISBN 978-1-4160-3966-2 [Book information]
  • Mitra AP. Bladder cancer, childhood. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 109-110. ISBN 978-1-4129-4989-7 [Book information]
  • Mitra AP. Chemotherapy. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 187-195. ISBN 978-1-4129-4989-7 [Book information]
  • Mitra AP. Technology, imaging. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 882-884. ISBN 978-1-4129-4989-7 [Book information]
  • Mitra AP. Assisted suicide. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 65-67. ISBN 978-1-4129-4989-7 [Book information]
  • Mitra AP. Developing countries. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 265-267. ISBN 978-1-4129-4989-7 [Book information]
  • Mitra AP. Roche group (Switzerland). In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 747-748. ISBN 978-1-4129-4989-7 [Book information]
  • Mitra AP. Daily life. In: Colditz GA (editor). Encyclopedia of Cancer and Society. Thousand Oaks, CA: Sage Publications, Inc.; 2007. p. 250-252. ISBN 978-1-4129-4989-7 [Book information]
 
 

Ph.D. DISSERTATION

 
 

SCIENTIFIC PRESENTATIONS AND PROCEEDINGS

REFEREED CONFERENCE POSTERS & PRESENTATIONS

  • Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. A combination of genomic markers and clinical variables provides superior prognostic performance in high-risk bladder cancer following cystectomy. 109th AUA Annual Meeting: 2014 May 16-21; Orlando, FL. (Moderated Poster)
  • Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Impact of gender on post-cystectomy bladder cancer outcomes: Differences in observations between matched and unmatched case-control approaches. 109th AUA Annual Meeting: 2014 May 16-21; Orlando, FL. (Moderated Poster)
  • Mitra AP, Schuckman AK, Skinner EC, Daneshmand S. Pelvic recurrence following radical cystectomy and its impact on bladder cancer outcomes. 109th AUA Annual Meeting: 2014 May 16-21; Orlando, FL. (Moderated Poster)
  • Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. Discovery and validation of a novel expression signature for predicting recurrence in high-risk bladder cancer post-cystectomy. 29th Annual EAU Congress: 2014 Apr 11-15; Stockholm, Sweden. (Moderated Poster) (Best Poster Award)
  • Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Identification of novel prognostic signatures in rhabdomyosarcoma by whole transcriptome expression profiling: a discovery and validation study. 105th AACR Annual Meeting: 2014 Apr 5-9; San Diego, CA. (Poster)
  • Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Long non-coding RNA promotes metastatic behavior in Ewing sarcoma. 105th AACR Annual Meeting: 2014 Apr 5-9; San Diego, CA. (Poster)
  • Mitra AP, Haydel D, Mitra SA, Wang L, Triche TJ. Differential diagnosis of small round cell tumors by transcriptome-wide expression profiling. 103rd USCAP Annual Meeting: 2014 Mar 1-7; San Diego, CA. (Presentation)
  • Mitra A, Lam L, Erho N, Ghadessi M, Vergara I, Alshalalfa M, Triche T, Davicioni E, Black P, Daneshmand S. Combination of genomic markers and clinical variables provides superior prognostic performance in high-risk bladder cancer following radical cystectomy. 14th Annual Meeting of the Society of Urologic Oncology: 2013 Dec 4-6; Bethesda, MD. (Presentation)
  • Mitra A, Skinner E, Schuckman A, Quinn D, Dorff T, Daneshmand S. A critical analysis of the influence of gender on bladder cancer outcomes following radical cystectomy. 14th Annual Meeting of the Society of Urologic Oncology: 2013 Dec 4-6; Bethesda, MD. (Poster)
  • Mitra A, Alemozaffar M, Harris B, Schuckman A, Miranda G, Skinner E, Daneshmand S. Outcomes following urothelial recurrence in bladder cancer patients undergoing radical cystectomy. 14th Annual Meeting of the Society of Urologic Oncology: 2013 Dec 4-6; Bethesda, MD. (Poster)
  • Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Outcomes following radical cystectomy for bladder cancer: A critical analysis of the influence of patient gender. 89th Western Section AUA Annual Meeting: 2013 Nov 3-7; Monterey, CA. (Moderated Poster)
  • Mitra AP, Schuckman AK, Skinner EC, Daneshmand S. Pelvic recurrence following radical cystectomy for urothelial carcinoma of the bladder. 89th Western Section AUA Annual Meeting: 2013 Nov 3-7; Monterey, CA. (Moderated Poster) (First Place, Best of Session Award)
  • Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Discovery and validation of novel prognostic genomic signatures in rhabdomyosarcoma. AACR Special Conference – Pediatric Cancer at the Crossroads: Translating Discovery Into Improved Outcomes: 2013 Nov 3-6; San Diego, CA. (Poster)
  • Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Therapeutic importance of a long non-coding RNA in Ewing sarcoma. AACR Special Conference – Pediatric Cancer at the Crossroads: Translating Discovery Into Improved Outcomes: 2013 Nov 3-6; San Diego, CA. (Poster)
  • Feng FY, Ghadessi M, Davicioni E, Crisan A, Erho N, Mitra AP, Triche TJ, Jenkins RB, Ross AE, Schaeffer EM. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. 55th ASTRO Annual Meeting: 2013 Sep 22-25; Atlanta, GA. (Presentation)
  • Badani K, Thompson D, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra A, Wood P, Hornberger J. Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group. 33rd Congress of the Société Internationale d’Urologie: 2013 Sep 8-12; Vancouver, BC. (Moderated Poster) (Best Poster Award)
  • Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Genomic and epigenomic interactions of an Ewing sarcoma-specific long non-coding RNA. AACR Special Conference on Chromatin and Epigenetics in Cancer: 2013 Jun 19-22; Atlanta, GA. (Presentation)
  • Mitra AP, Erho N, Lam LLC, Vergara IA, Sierocinski T, Zimmermann B, Haddad Z, Ghadessi M, Crisan A, Triche TJ, Daneshmand S, Buerki C, Davicioni E, Black PC. Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer. 49th ASCO Annual Meeting: 2013 May 31-Jun 4; Chicago, IL. (Poster)
  • Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Feng FY, Schaeffer EM. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. 49th ASCO Annual Meeting: 2013 May 31-Jun 4; Chicago, IL. (Poster Discussion)
  • Mitra AP, Schuckman AK, Skinner EC, Miranda G, Daneshmand S. Evolving trends in urinary diversion following radical cystectomy: A single-institution experience over 25 years. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Presentation)
  • Mitra AP, Skinner EC, Schuckman AK, Miranda G, Daneshmand S. Blood loss during radical cystectomy and concomitant transfusions: Influencing factors and impact on patient outcomes. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)
  • Alemozaffar M, Mitra A, Fairey A, Lieskovsky G, Daneshmand S. Post-prostatectomy survival outcomes in patients with pT3 stage disease and lymph node involvement (pT3N+M0) with subsequent observation or adjuvant therapy. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Presentation)
  • Karnes RJ, Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJS, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, Vergara IA, Triche TJ, Black PC, Thompson RH, Jenkins RB. Validation of a genomic classifier that predicts metastatic disease progression in men with high risk pathological features post-prostatectomy. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Presentation) (AUA Take Home Messages - Prostate Cancer; Best of AUA)
  • Daneshmand S, Ahmadi H, Schuckman AK, Miranda G, Mitra AP, Djaladat H. Enhanced recovery after surgery in patients undergoing radical cystectomy for bladder cancer. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (Best Poster Award; AUA Take Home Messages - Bladder Cancer)
  • Cooperberg M, Crisan A, Mitra A, Ghadessi M, Buerki C, Davicioni E. Combined value of genomic biomarkers and CAPRA-S in predicting prostate cancer death in a high-risk surgical cohort. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (AUA Take Home Messages - Prostate Cancer)
  • Crisan A, Vergara I, Ghadessi M, Thompson D, Buerki C, Erho N, Siercocinski T, Haddad Z, Black P, Mitra A, Davicioni E, Jenkins R. Clinical and genomic analysis of metastatic disease progression in a background of biochemical recurrence. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)
  • Dolginow D, Crisan A, Buerki C, Ghadessi M, Mitra AP, Erho N, Vergara IA, Haddad Z, Sierocinski T, Triche TJ, Davicioni E. Evaluation of a genomic classifier for improved risk stratification in prostate cancer patients with specific adverse pathologies after surgery. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (AUA Take Home Messages - Prostate Cancer)
  • Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Feng FY, Schaeffer EM. Performance of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (Best Poster Award)
  • Ross A, Ghadessi M, Crisan A, Buerki C, Erho N, Vergara I, Haddad Z, Harko S, Mitra A, Thompson D, Triche T, Davicioni E, Schaeffer E. Comparison of clinical and genomic models for prediction of rapid metastatic disease after radical prostatectomy. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster) (AUA Take Home Messages - Prostate Cancer)
  • Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhaeuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Over decades, radical cystectomy with extended lymphadenectomy provides predictable outcomes to patients with muscle invasive bladder cancer - notwithstanding bladder cancer remains as deadly as 30 years ago. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)
  • Kluth LA, Xylinas E, Rink M, Kent M, Sjoberg D, Babjuk M, Brisuda A, Aziz A, Fritsche H, Comploj E, Pycha A, Sundi D, Bivalacqua T, Novara G, Baniel J, Mano R, Gontero P, Svatek RS, Lusuardi L, Mitra A, Daneshmand S, Galsky MD, Lotan Y, Scherr DS, Shariat SF. Prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder. 108th AUA Annual Meeting: 2013 May 4-8; San Diego, CA. (Moderated Poster)
  • Mitra AP, Mitra SA, Buckley JD, Kapranov P, Anderson JR, Skapek SX, Hawkins DS, Triche TJ. Prognostic value of coding and non-coding genomic meta-features in rhabdomyosarcoma. 104th AACR Annual Meeting: 2013 Apr 6-10; Washington, DC. (Poster)
  • Mitra AP, Haydel D, Mitra SA, Dunne J, Silveria S, Wang L, Triche TJ. Diagnosing small round cell tumors using whole transcriptome expression profiling. 104th AACR Annual Meeting: 2013 Apr 6-10; Washington, DC. (Poster)
  • Mitra SA, Mitra AP, Buckley JD, May WA, Kapranov P, Arceci RJ, Triche TJ. Influence of a long non-coding RNA on epigenetic, genetic and phenotypic changes in Ewing sarcoma. 104th AACR Annual Meeting: 2013 Apr 6-10; Washington, DC. (Poster)
  • Kluth LA, Xylinas E, Rink M, Kent M, Sjoberg D, Babjuk M, Brisuda A, Aziz A, Fritsche H-M, Comploj E, Pycha A, Sundi D, Bivalacqua T, Novara G, Baniel J, Mano R, Gontero P, Svatek RS, Lusuardi L, Mitra A, Daneshmand S, Lotan Y, Scherr DS, Shariat SF. Validation of prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder. 28th Annual EAU Congress: 2013 Mar 15-19; Milan, Italy. (Moderated Poster)
  • Jayaratna IS, Mitra AP, Dedhia R, Asbaghi S, Teruya KK, Tygenhof E, Schuckman AK. Inguinal lymph node dissection for penile carcinoma: Postoperative complications using a validated classification system. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)
  • Cooperberg MR, Crisan A, Mitra AP, Ghadessi M, Buerki C, Davicioni E. A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)
  • Badani KK, Thompson DJS, Mitra AP, Ghadessi M, Buerki C, Davicioni E, Wood PJ. Evaluation of a genomic-based prognostic test for metastasis in high-risk post-prostatectomy patients: Does it impact physician decision making? ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)
  • Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJS, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, Vergara IA, Triche TJ, Black PC, Thompson RH, Karnes RJ, Jenkins RB. Validation of a genomic classifier that predicts metastatic disease progression in men with high-risk pathologic features postprostatectomy. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)
  • Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Schaeffer EM, Feng FY. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2013 Feb 14-16; Orlando, FL. (Poster)
  • Mitra A, Birkhahn M, Williams A, Barr N, Skinner E, Stein J, Skinner D, Tai YC, Datar R, Cote R. Detection and characterization of bladder cancer cells in urine using a novel membrane microfiltration device. 13th Annual Meeting of the Society of Urologic Oncology: 2012 Nov 28-30; Bethesda, MD. (Poster)
  • Mitra A, Schuckman A, Skinner E, Miranda G, Daneshmand S. Trends in urinary diversion following radical cystectomy: Long-term experience at the University of Southern California. 13th Annual Meeting of the Society of Urologic Oncology: 2012 Nov 28-30; Bethesda, MD. (Poster)
  • Mitra A, Ghadessi M, Bergstralh EJ, Buerki C, Erho N, Crisan A, Sierocinski T, Haddad Z, Vergara IA, Thompson DJS, Carlson R, Klee GG, Ballman KV, Kollmeyer TM, Triche TJ, Davicioni E, Black PC, Thompson RH, Karnes RJ, Jenkins RB. Development and validation of a novel genomic classifier for predicting metastatic prostate cancer in patients undergoing radical prostatectomy. 13th Annual Meeting of the Society of Urologic Oncology: 2012 Nov 28-30; Bethesda, MD. (Poster)
  • Bartsch G, Mitra A, Mitra S, Almal A, Steven K, Fry D, Lenehan P, Worzel W, Cote R. Artificial intelligence and machine-learning algorithms with gene expression profiling: A potential approach to predicting superficial bladder cancer recurrence at initial presentation. 13th Annual Meeting of the Society of Urologic Oncology: 2012 Nov 28-30; Bethesda, MD. (Poster)
  • Ghadessi M, Bergstralh EJ, Buerki C, Black PC, Erho NG, Crisan A, Mitra AP, Davicioni E, Feng F, Jenkins RB. Validation of a genomic-clinical classifier for predicting clinical progression in postprostatectomy high-risk prostate cancer. 54th ASTRO Annual Meeting: 2012 Oct 28-31; Boston, MA. (Presentation)
  • Davicioni E, Mitra AP, Buerki C, Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Sierocinski T, Haddad Z, Vergara IA, Thompson DJS, Carlson R, Klee GG, Ballman KV, Fink S, Kollmeyer TM, Triche TJ, Black PC, Thompson RH, Karnes RJ, Jenkins RB. Development and validation of a novel genomic classifier for predicting metastatic prostate cancer in patients undergoing radical prostatectomy. 19th Annual Prostate Cancer Foundation Scientific Retreat: 2012 Oct 25-27; Carlsbad, CA. (Poster)
  • Mitra AP, Birkhahn M, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. Use of a novel precision-engineered membrane microfiltration device for bladder cancer detection. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Presentation)
  • Mitra AP, Skinner EC, Quinn DI, Dorff TB, Miranda G, Daneshmand S. Critical analysis of gender differences on outcomes following radical cystectomy for bladder cancer. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Moderated Poster)
  • Mitra AP, Skinner EC, Miranda G, Daneshmand S. Blood loss during radical cystectomy: Comprehensive analysis of contributing factors and influence on patient outcome. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Moderated Poster)
  • Mitra AP, Schuckman A, Skinner EC, Miranda G, Daneshmand S. Evolution of urinary diversion following radical cystectomy: An institution's 25-year experience. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Moderated Poster)
  • Mitra AP, Daneshmand S, Dorff TB, Miranda G, Schuckman AK, Gill IS, Skinner DG, Skinner EC, Quinn DI. Impact of cigarette smoking on oncological outcomes following radical cystectomy for bladder cancer. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Poster)
  • Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Influence of squamous and glandular differentiation on bladder cancer outcome: A matched case-control analysis. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Poster)
  • Jayaratna IS, Mitra AP, Fairey AS, Schwartz RL, Dedhia RD, Asbaghi SA, Teruya K, Quinn DI, Dorff TB, Schuckman AK. Prognostic factors and survival outcomes of penile carcinoma at the University of Southern California. 88th Western Section AUA Annual Meeting: 2012 Oct 7-12; Big Island, HI. (Poster)
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen SG, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Defining a nine-biomarker panel for predicting bladder cancer outcome in combination with smoking intensity: A report from the Los Angeles Cancer Surveillance Program. 48th ASCO Annual Meeting: 2012 Jun 1-5; Chicago, IL. (Poster) (Conquer Cancer Foundation of ASCO Merit Award)
  • Daneshmand S, Skinner EC, Miranda G, Mitra AP. A pre-cystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. 48th ASCO Annual Meeting: 2012 Jun 1-5; Chicago, IL. (Poster)
  • Buerki C, Mitra AP, Black PC, Ghadessi M, Bergstralh EJ, Erho N, Carlson R, Crisan A, Sierocinski T, Zimmermann B, Haddad Z, Vergara IA, Ballman KV, Klee GG, Fink S, Kollmeyer TM, Triche TJ, Davicioni E, Karnes RJ, Jenkins RB. Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer. 48th ASCO Annual Meeting: 2012 Jun 1-5; Chicago, IL. (Poster Discussion)
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program. 107th AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster) (Best of AUA)
  • Mitra AP, Birkhahn M, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. A novel precision-engineered membrane microfiltration device for capture and characterization of bladder cancer cells in urine. 107th AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster)
  • Mitra AP, Bartsch G, Mitra SA, Almal AA, Steven KE, Fry DW, Lenehan PF, Cote RJ, Worzel WP. Using artificial intelligence and machine-learning algorithms with gene expression profiling to predict superficial bladder cancer recurrence at initial presentation. 107th AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster) (Best Poster Award; Best of AUA)
  • Mitra AP, Masic S, Skinner EC, Cai J, Miranda G, Daneshmand S. Diagnostic and surgical delays in bladder cancer and its impact on clinical outcome. 107th AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster) (AUA Take Home Messages - Bladder Cancer)
  • Mitra AP, Syan R, Skinner EC, Miranda G, Daneshmand S. Factors influencing lymph node yield during radical cystectomy with extended pelvic lymphadenectomy: Single-institution experience with a standardized dissection template. 107th AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster)
  • Wopat RA, Skinner EC, Mitra AP, Cai J, Miranda G, Daneshmand S. Outcomes in patients undergoing radical cystectomy for recurrent bladder cancer following prior partial cystectomy. 107th AUA Annual Meeting: 2012 May 19-23; Atlanta, GA. (Moderated Poster)
  • Mitra AP, Buckley JD, Mitra SA, Davicioni E, Anderson JR, Kapranov P, Skapek SX, Hawkins DS, Triche TJ. A non-coding RNA panel is prognostically superior to standard pathologic criteria and coding transcripts in rhabdomyosarcoma. 103rd AACR Annual Meeting: 2012 Mar 31-Apr 4; Chicago, IL. (Poster)
  • Jayaratna IS, Schwartz RL, Mitra AP, Cai J, Ma Y, Quinn DI, Dorff TB, Schuckman A. The University of Southern California penile cancer experience: Clinicopathologic characteristics of patients from 1991-2011. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2012 Feb 2-4; San Francisco, CA. (Poster)
  • Schwartz RL, Jayaratna IS, Mitra AP, Da Silva D, Kast WM, Chen M, Ma Y, Quinn DI, Dorff TB, Schuckman A. HPV status in relation to clinicopathologic variables in patients with penile cancer at Los Angeles County-USC Medical Center. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2012 Feb 2-4; San Francisco, CA. (Poster)
  • Mitra AP, Buckley JD, Mitra SA, Davicioni E, Anderson JR, Kapranov P, Skapek SX, Hawkins DS, Triche TJ. A non-coding RNA panel predicts intermediate-risk childhood rhabdomyosarcoma prognosis better than standard pathologic criteria and coding genes. AACR Noncoding RNAs and Cancer Conference: 2012 Jan 8-11; Miami, FL. (Poster)
  • Mitra AP, Mitra SA, Buckley JD, Sorensen PHB, Reynolds CP, Arceci RJ, Milos P, St. Laurent G, Kapranov P, Triche TJ. Human genome contains a large number of very long intergenic transcribed regions, some of which are associated with cancer outcome. AACR Noncoding RNAs and Cancer Conference: 2012 Jan 8-11; Miami, FL. (Poster)
  • Jayaratna I, Schwartz R, Mitra A, Cai J, Ma Y, Quinn D, Dorff T, Schuckman A. The USC penile cancer experience: Clinicopathologic characteristics of patients from 1991-2011. 12th Annual Meeting of the Society of Urologic Oncology: 2011 Nov 30-Dec 2; Bethesda, MD. (Poster)
  • Schwartz RL, Jayaratna I, Mitra AP, Da Silva D, Kast WM, Chen M, Ma Y, Quinn DI, Dorff TB, Schuckman AK. HPV status in relation to clinicopathological characteristics in penile cancer patients at Los Angeles County-USC (LAC-USC) Medical Center. 12th Annual Meeting of the Society of Urologic Oncology: 2011 Nov 30-Dec 2; Bethesda, MD. (Poster)
  • Bartsch C, Mitra A, Bartsch G, Skinner E, Skinner D, Steven K, Cote R. An angiogenesis marker panel predicts the recurrence of non-invasive papillary bladder cancer at initial diagnosis. 63rd Annual Congress of the German Society of Urology: 2011 Sep 14-17; Hamburg, Germany. (Moderated Poster)
  • Zehnder P, Skinner EC, Studer UE, Thalmann GN, Miranda G, Cai J, Mitra AP, Skinner DG, Quinn DI, Gill IS. The outcome of patients undergoing radical cystectomy with extended lymph node dissection remains unimproved over the last 35 years. 63rd Annual Congress of the German Society of Urology: 2011 Sep 14-17; Hamburg, Germany. (Moderated Poster)
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Identification of a biomarker panel that predicts bladder cancer outcome independent of routine prognostic factors and smoking history. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)
  • Mitra AP, Skinner EC, Miranda G, Daneshmand S. A decision tree approach to identifying patients with clinical T2 bladder cancer who may benefit from neoadjuvant chemotherapy. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)
  • Mitra AP, Bartsch CC, Bartsch G, Skinner EC, Skinner DG, Steven KE, Cote RJ. Potential of angiogenesis pathway-derived markers in predicting noninvasive bladder cancer recurrence. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Moderated Poster) (First Place, Best of Session Award; Third Place, Overall Award)
  • Mitra AP, Bartsch CC, Bartsch G, Miranda G, Skinner EC, Daneshmand S. Does presence of squamous and glandular differentiation in bladder transitional cell carcinoma portend poor prognosis? An intensive case-control analysis. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Moderated Poster)
  • Mitra AP, Bartsch G, Almal AA, Steven KE, Fry DW, Lenehan PF, Cote RJ, Worzel WP. Employment of gene expression profiling and a machine-learning algorithm to predict superficial bladder cancer recurrence at initial presentation. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Moderated Poster)
  • Masic S, Mitra AP, Skinner EC, Cai J, Miranda G, Daneshmand S. Diagnostic and surgical delay in bladder cancer and its impact on patient outcome. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)
  • Syan R, Mitra AP, Skinner EC, Miranda G, Daneshmand S. Factors affecting lymph node yield during radical cystectomy. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)
  • Harris BN, Mitra AP, Skinner EC, Miranda G, Daneshmand S. Survival following urothelial recurrence in patients post-radical cystectomy for transitional cell carcinoma of the bladder. 87th Western Section AUA Annual Meeting: 2011 Aug 21-25; Vancouver, BC. (Presentation)
  • Mitra A, Quinn D, Dorff T, Skinner E, Schuckman A, Miranda G, Gill I, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer patients following radical cystectomy. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Presentation)
  • Mitra A, Skinner E, Lieskovsky G, Schuckman A, Boyd S, Miranda G, Skinner D, Daneshmand S. Radical cystectomy for transitional cell carcinoma of the bladder - The USC experience. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Presentation)
  • Mitra A, Tsao-Wei D, Dorff T, Groshen S, Miranda G, Schuckman A, Daneshmand S, Gill I, Skinner D, Skinner E, Quinn D. Influence of smoking history on bladder cancer patient outcome following radical cystectomy. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)
  • Mitra A, Castelao J, Hawes D, Tsao-Wei D, Jiang X, Shi S, Young L, Datar R, Skinner E, Stein J, Groshen S, Yu M, Ross R, Skinner D, Cortessis V, Cote R. Protein alterations predict bladder cancer outcome independent of clinicopathologic prognostic criteria and tobacco smoke exposure. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)
  • Bartsch C, Mitra A, Bartsch G, Skinner E, Skinner D, Steven K, Cote R. An angiogenesis-marker panel predicts noninvasive papillary bladder cancer recurrence at initial presentation. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Presentation)
  • Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Orthotopic urinary diversion in male patients with pT4a bladder cancer. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)
  • Abdelsayed GA, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. A pre-cystectomy modeling approach for predicting pathologic stage in clinically organ-confined bladder cancer. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)
  • Zehnder P, Daneshmand S, Leahy M, Cai J, Miranda G, Mitra A, Bartsch G, Skinner E, Gill I. Outcome analysis of patients with exclusively carcinoma in situ (CIS) following radical cystectomy and no previous history of lamina propria invasion. 106th AUA Annual Meeting: 2011 May 14-19; Washington, DC. (Moderated Poster)
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Using molecular alterations to predict bladder cancer prognosis independent of clinicopathologic parameters and cigarette smoke exposure. 102nd AACR Annual Meeting: 2011 Apr 2-6; Orlando, FL. (Poster)
  • Zehnder P, Daneshmand S, Leahy M, Skinner E, Cai J, Miranda G, Mitra A, Bartsch G, Gill I. Outcome in patients exclusively with carcinoma in situ (CIS) following radical cystectomy. 11th Annual Meeting of the Society of Urologic Oncology: 2010 Dec 8-10; Bethesda, MD. (Poster)
  • Mitra AP, Hawes D, Tsao-Wei DD, Shi SR, Datar RH, Groshen S, Stein JP, Skinner EC, Skinner DG, Ross RK, Cote RJ. Combination of molecular alterations predict bladder cancer outcome independent of standard prognostic criteria and carcinogen exposure. 86th Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Presentation)
  • Mitra AP, Miranda G, Dorff TB, Quinn DI, Schuckman AK, Skinner EC, Daneshmand S. Factors predictive of patient outcome following bladder cancer recurrence after radical cystectomy. 86th Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Moderated Poster)
  • Mitra AP, Tsao-Wei DD, Quinn DI, Dorff TB, Miranda G, Skinner EC, Skinner DG. Impact of smoking habits on patient outcome following radical cystectomy. 86th Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Moderated Poster)
  • Zehnder P, Skinner EC, Studer UE, Miranda G, Cai J, Mitra AP, Skinner DG, Quinn DI, Gill IS. Bladder cancer, an unaltered deadly disease over the last four decades. 86th Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Presentation)
  • Zehnder P, Skinner EC, Studer UE, Miranda G, Cai J, Mitra AP, Skinner DG, Quinn DI, Gill IS. Meticulous extended lymph node dissection during radical cystectomy allows for recurrence risk stratification according to total nodal yield and positive nodes. 86th Western Section AUA Annual Meeting: 2010 Oct 24-29; Big Island, HI. (Moderated Poster)
  • Mitra A, Jiang X, Castelao JE, Hawes D, Tsao-Wei DD, Shi SR, Young L, Datar RH, Skinner EC, Stein JP, Groshen S, Ross RK, Triche TJ, Skinner DG, Jones PA, Cote RJ. Molecular alterations in bladder cancer associated with carcinogen exposure and their prognostic impact: a Los Angeles County experience. 105th AUA Annual Meeting: 2010 May 29-Jun 3; San Francisco, CA. (Moderated Poster)
  • Lerner SP, Stadler WM, Groshen S, Cai J, Mitra AP, Tuazon ED, Skinner DG, Raghavan D, Esrig D, Steinberg GD, Klotz L, Hall MC, Cote RJ. Cell cycle regulatory protein alterations in a prospective study of patients with organ-confined bladder cancer following radical cystectomy. 105th AUA Annual Meeting: 2010 May 29-Jun 3; San Francisco, CA. (Moderated Poster)
  • Mitra AP, Jiang X, Castelao JE, Hawes D, Tsao-Wei DD, Shi SR, Young L, Datar RH, Gago-Dominguez M, Stein JP, Skinner EC, Groshen S, Ross RK, Skinner DG, Triche TJ, Jones PA, Cote RJ. Effects of smoking on the molecular pathology of urinary bladder cancer and its prognostic importance. 101st AACR Annual Meeting: 2010 Apr 17-21; Washington, DC. (Poster)
  • Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. A concise 4-gene panel can predict clinical outcome in urinary bladder cancer. 104th AUA Annual Meeting: 2009 Apr 25-30; Chicago, IL. (Presentation)
  • Mitra AP, Pagliarulo V, Yang D, Waldman FM, Groshen S, Cote RJ. A 4-gene panel can predict clinical outcome across all stages of urinary bladder cancer. 100th AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster)
  • Mitra AP, Jiang X, Hawes D, Tsao-Wei DD, Shi SR, Castelao JE, Groshen S, Cote RJ. Associations of smoking and non-steriodal anti-inflammatory drug use with molecular alterations in urinary bladder cancer. 100th AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster) (Outstanding Clinical Scholar Award)
  • Jiang X, Mitra AP, Castelao JE, Xue S, Diep AT, Haile RW, Gago-Dominguez M. p53 overexpression and colorectal cancer. 100th AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster)
  • Jiang X, Mitra AP, Castelao JE, Xue S, Diep AT, Haile RW, Gago-Dominguez M. Distinguishing clinicopathologic and molecular characteristics of proximal and distal colorectal cancer. 100th AACR Annual Meeting: 2009 Apr 18-22; Denver, CO. (Poster)
  • Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. Use of a 4-gene panel to predict prognosis in urinary bladder cancer. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. (Poster) [Virtual Meeting]
  • Birkhahn M, Mitra AP, Bartsch G Jr., Ye W, Groshen S, Steven KE, Cote RJ. Use of quantitative expression profiling to identify genes that predict prognosis in Ta bladder cancer at first presentation. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. (Poster)
  • Youssef RF, Mitra AP, Abol-Enein H, Penson D, Mosbah A, Cai J, Groshen S, Skinner DG, Ghoneim MA, Cote RJ. Adenocarcinoma of the urinary bladder: Outcome of 322 cases from Egypt and USA. ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. (Poster)
  • Mitra AP, Yang D, Pagliarulo V, Datar RH, Groshen SG, Cote RJ. A four-gene panel for prediction of clinical outcome in urinary bladder cancer. 99th AACR Annual Meeting: 2008 Apr 12-16; San Diego, CA. (Poster)
  • Birkhahn M, Williams AW, Mitra AP, Ye W, Zhong JF, Datar RH, Groshen SG, Lam G, Steven KE, Cote RJ. Molecular markers for tumor recurrence and progression in low and high grade pTa bladder cancer. 99th AACR Annual Meeting: 2008 Apr 12-16; San Diego, CA. (Poster)
  • Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. Generation of a concise prognostic gene panel for urinary bladder cancer. USC Keck School of Medicine – Annual Pathology Conference: 2008 Feb 1-2; Oxnard, CA. (Presentation)
  • Mitra AP, Yang D, Pagliarulo V, Groshen SG, Cote RJ. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. 19th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: 2007 Oct 22-26; San Francisco, CA. (Poster) (Scholar-in-Training Award)
  • Mitra AP, Almal A, Pagliarulo V, George B, Yang D, Groshen S, Worzel WP, Cote RJ. Applying unsupervised and supervised techniques to analyze gene expression profiles in bladder cancer. USC Keck School of Medicine – Department of Pathology Annual Retreat: 2007 Jan 26-27; Palm Desert, CA. (Presentation)
  • Mitra AP, Almal AA, George B, Fry DW, Lenehan PF, Pagliarulo V, Cote RJ, Datar RH, Worzel WP. Application of genetic programming in analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. USC Keck School of Medicine – Department of Pathology Annual Retreat: 2006 Jan 20-21; Oxnard, CA. (PosterePosters.net ID# EP10622

 

REFEREED CONFERENCE PAPERS AND PROCEEDINGS

  • Mitra AP, Lam LL, Ghadessi M, Erho N, Vergara IA, Alshalalfa M, Haddad Z, Sierocinski T, Triche TJ, Skinner EC, Davicioni E, Daneshmand S, Black PC. A combination of genomic markers and clinical variables provides superior prognostic performance in high-risk bladder cancer following cystectomy. J Urol 191(4S):e429, 2014.
  • Mitra AP, Skinner EC, Schuckman AK, Quinn DI, Dorff TB, Daneshmand S. Impact of gender on post-cystectomy bladder cancer outcomes: Differences in observations between matched and unmatched case-control approaches. J Urol 191(4S):e688-e689, 2014.
  • Mitra AP, Schuckman AK, Skinner EC, Daneshmand S. Pelvic recurrence following radical cystectomy and its impact on bladder cancer outcomes. J Urol 191(4S):e691, 2014.
  • Mitra AP, Haydel D, Mitra SA, Wang L, Triche TJ. Differential diagnosis of small round cell tumors by transcriptome-wide expression profiling. Mod Pathol 27(S2):471A, 2014.
  • Feng FY, Ghadessi M, Davicioni E, Crisan A, Erho N, Mitra AP, Triche TJ, Jenkins RB, Ross AE, Schaeffer EM. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. Int J Radiat Oncol Biol Phys 87(2S):S125, 2013.
  • Badani K, Thompson D, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra A, Wood P, Hornberger J. Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group. Urology 82(3S):S151, 2013.
  • Mitra AP, Erho N, Lam LLC, Vergara IA, Sierocinski T, Zimmermann B, Haddad Z, Ghadessi M, Crisan A, Triche TJ, Daneshmand S, Buerki C, Davicioni E, Black PC. Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer. J Clin Oncol 31(15S, Part I of II):294s, 2013.
  • Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Feng FY, Schaeffer EM. Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. J Clin Oncol 31(15S, Part I of II):316s, 2013.
  • Badani KK, Thompson DJS, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra AP, Wood PJ, Hornberger JC. Impact of a genomic classifier of metastatic risk on treatment recommendations post-radical prostatectomy: Report from the DECIDE study group. J Clin Oncol 31(suppl): e16044, 2013.
  • Mitra AP, Schuckman AK, Skinner EC, Miranda G, Daneshmand S. Evolving trends in urinary diversion following radical cystectomy: A single-institution experience over 25 years. J Urol 189(4S):e513-e514, 2013.
  • Mitra AP, Skinner EC, Schuckman AK, Miranda G, Daneshmand S. Blood loss during radical cystectomy and concomitant transfusions: Influencing factors and impact on patient outcomes. J Urol 189(4S):e211-e212, 2013.
  • Alemozaffar M, Mitra A, Fairey A, Lieskovsky G, Daneshmand S. Post-prostatectomy survival outcomes in patients with pT3 stage disease and lymph node involvement (pT3N+M0) with subsequent observation or adjuvant therapy. J Urol 189(4S):e295, 2013.
  • Karnes RJ, Ghadessi M, Bergstralh EJ, Erho N, Crisan A, Davicioni E, Buerki C, Mitra AP, Thompson DJS, Carlson R, Haddad Z, Zimmermann B, Ballman KV, Kollmeyer TM, Sierocinski T, Vergara IA, Triche TJ, Black PC, Thompson RH, Jenkins RB. Validation of a genomic classifier that predicts metastatic disease progression in men with high risk pathological features post-prostatectomy. J Urol 189(4S):e872-e873, 2013. [Citing articles]
  • Daneshmand S, Ahmadi H, Schuckman AK, Miranda G, Mitra AP, Djaladat H. Enhanced recovery after surgery in patients undergoing radical cystectomy for bladder cancer. J Urol 189(4S):e210-e211, 2013.
  • Cooperberg M, Crisan A, Mitra A, Ghadessi M, Buerki C, Davicioni E. Combined value of genomic biomarkers and CAPRA-S in predicting prostate cancer death in a high-risk surgical cohort. J Urol 189(4S):e919, 2013.
  • Crisan A, Vergara I, Ghadessi M, Thompson D, Buerki C, Erho N, Siercocinski T, Haddad Z, Black P, Mitra A, Davicioni E, Jenkins R. Clinical and genomic analysis of metastatic disease progression in a background of biochemical recurrence. J Urol 189(4S):e918, 2013. [Citing articles]
  • Dolginow D, Crisan A, Buerki C, Ghadessi M, Mitra AP, Erho N, Vergara IA, Haddad Z, Sierocinski T, Triche TJ, Davicioni E. Evaluation of a genomic classifier for improved risk stratification in prostate cancer patients with specific adverse pathologies after surgery. J Urol 189(4S):e914-e915, 2013.
  • Ross AE, Ghadessi M, Davicioni E, Crisan A, Buerki C, Erho N, Mitra AP, Thompson DJS, Triche TJ, Feng FY, Schaeffer EM. Performance of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy. J Urol 189(4S):e918, 2013.
  • Ross A, Ghadessi M, Crisan A, Buerki C, Erho N, Vergara I, Haddad Z, Harko S, Mitra A, Thompson D, Triche T, Davicioni E, Schaeffer E. Comparison of clinical and genomic models for prediction of rapid metastatic disease after radical prostatectomy. J Urol 189(4S):e914, 2013.
  • Zehnder P, Studer UE, Skinner EC, Thalmann GN, Miranda G, Roth B, Cai J, Birkhaeuser FD, Mitra AP, Burkhard FC, Dorin RP, Daneshmand S, Skinner DG, Gill IS. Over decades, radical cystectomy with extended lymphadenectomy provides predictable outcomes to patients with muscle invasive bladder cancer - notwithstanding bladder cancer remains as deadly as 30 years ago. J Urol 189(4S):e666, 2013.
  • Kluth LA, Xylinas E, Rink M, Kent M, Sjoberg D, Babjuk M, Brisuda A, Aziz A, Fritsche H, Comploj E, Pycha A, Sundi D, Bivalacqua T, Novara G, Baniel J, Mano R, Gontero P, Svatek RS, Lusuardi L, Mitra A, Daneshmand S, Galsky MD, Lotan Y, Scherr DS, Shariat SF. Prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder. J Urol 189(4S):e766, 2013.
  • Kluth LA, Xylinas E, Rink M, Kent M, Sjoberg D, Babjuk M, Brisuda A, Aziz A, Fritsche H-M, Comploj E, Pycha A, Sundi D, Bivalacqua T, Novara G, Baniel J, Mano R, Gontero P, Svatek RS, Lusuardi L, Mitra A, Daneshmand S, Lotan Y, Scherr DS, Shariat SF. Validation of prognostic value of Bajorin criteria for cancer-specific survival in patients who have disease recurrence after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol Suppl 12(1):e815-e816, 2013.
  • Ghadessi M, Bergstralh EJ, Buerki C, Black PC, Erho NG, Crisan A, Mitra AP, Davicioni E, Feng F, Jenkins RB. Validation of a genomic-clinical classifier for predicting clinical progression in postprostatectomy high-risk prostate cancer. Int J Radiat Oncol Biol Phys 84(3S):S58-S59, 2012.
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen SG, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Defining a nine-biomarker panel for predicting bladder cancer outcome in combination with smoking intensity: A report from the Los Angeles Cancer Surveillance Program. J Clin Oncol 30(15S, Part I of II):295s, 2012.
  • Daneshmand S, Skinner EC, Miranda G, Mitra AP. A pre-cystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer. J Clin Oncol 30(15S, Part I of II):296s, 2012.
  • Buerki C, Mitra AP, Black PC, Ghadessi M, Bergstralh EJ, Erho N, Carlson R, Crisan A, Sierocinski T, Zimmermann B, Haddad Z, Vergara IA, Ballman KV, Klee GG, Fink S, Kollmeyer TM, Triche TJ, Davicioni E, Karnes RJ, Jenkins RB. Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer. J Clin Oncol 30(15S, Part I of II):293s, 2012.
  • Mitra AP, Castelao JE, Hawes D, Tsao-Wei DD, Jiang X, Shi SR, Young LL, Datar RH, Skinner EC, Stein JP, Groshen S, Yu MC, Ross RK, Skinner DG, Cortessis VK, Cote RJ. Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program. J Urol 187(4S):e229, 2012.
  • Mitra AP, Birkhahn M, Williams AJ, Barr NJ, Skinner EC, Stein JP, Skinner DG, Tai YC, Datar RH, Cote RJ. A novel precision-engineered membrane microfiltration device for capture and characterization of bladder cancer cells in urine. J Urol 187(4S):e517, 2012.
  • Mitra AP, Bartsch G, Mitra SA, Almal AA, Steven KE, Fry DW, Lenehan PF, Cote RJ, Worzel WP. Using artificial intelligence and machine-learning algorithms with gene expression profiling to predict superficial bladder cancer recurrence at initial presentation. J Urol 187(4S):e361, 2012.
  • Mitra AP, Masic S, Skinner EC, Cai J, Miranda G, Daneshmand S. Diagnostic and surgical delays in bladder cancer and its impact on clinical outcome. J Urol 187(4S):e642-e643, 2012.
  • Mitra AP, Syan R, Skinner EC, Miranda G, Daneshmand S. Factors influencing lymph node yield during radical cystectomy with extended pelvic lymphadenectomy: Single-institution experience with a standardized dissection template. J Urol 187(4S):e771, 2012. [Citing articles]
  • Wopat RA, Skinner EC, Mitra AP, Cai J, Miranda G, Daneshmand S. Outcomes in patients undergoing radical cystectomy for recurrent bladder cancer following prior partial cystectomy. J Urol 187(4S):e707, 2012.
  • Mitra A, Quinn D, Dorff T, Skinner E, Schuckman A, Miranda G, Gill I, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer patients following radical cystectomy. J Urol 185(4S):e793-e794, 2011.
  • Mitra A, Skinner E, Lieskovsky G, Schuckman A, Boyd S, Miranda G, Skinner D, Daneshmand S. Radical cystectomy for transitional cell carcinoma of the bladder – The USC experience. J Urol 185(4S):e739, 2011.
  • Mitra A, Tsao-Wei D, Dorff T, Groshen S, Miranda G, Schuckman A, Daneshmand S, Gill I, Skinner D, Skinner E, Quinn D. Influence of smoking history on bladder cancer patient outcome following radical cystectomy. J Urol 185(4S):e638, 2011. [Citing articles]
  • Mitra A, Castelao J, Hawes D, Tsao-Wei D, Jiang X, Shi S, Young L, Datar R, Skinner E, Stein J, Groshen S, Yu M, Ross R, Skinner D, Cortessis V, Cote R. Protein alterations predict bladder cancer outcome independent of clinicopathologic prognostic criteria and tobacco smoke exposure. J Urol 185(4S):e425, 2011.
  • Bartsch C, Mitra A, Bartsch G, Skinner E, Skinner D, Steven K, Cote R. An angiogenesis-marker panel predicts noninvasive papillary bladder cancer recurrence at initial presentation. J Urol 185(4S):e664, 2011.
  • Djaladat H, Mitra AP, Miranda G, Skinner EC, Daneshmand S. Orthotopic urinary diversion in male patients with pT4a bladder cancer. J Urol 185(4S):e455, 2011.
  • Abdelsayed GA, Mitra AP, Cai J, Miranda G, Skinner EC, Daneshmand S. A pre-cystectomy modeling approach for predicting pathologic stage in clinically organ-confined bladder cancer. J Urol 185(4S):e755-e756, 2011.
  • Zehnder P, Daneshmand S, Leahy M, Cai J, Miranda G, Mitra A, Bartsch G, Skinner E, Gill I. Outcome analysis of patients with exclusively carcinoma in situ (CIS) following radical cystectomy and no previous history of lamina propria invasion. J Urol 185(4S):e702-e703, 2011.
  • Mitra A, Jiang X, Castelao J, Hawes D, Tsao-Wei D, Shi S, Young L, Datar R, Skinner E, Stein J, Groshen S, Ross R, Triche T, Skinner D, Jones P, Cote R. Molecular alterations in bladder cancer associated with carcinogen exposure and their prognostic impact: a Los Angeles County experience. J Urol 183(4S):e374, 2010.
  • Lerner SP, Stadler W, Groshen S, Cai J, Mitra AP, Tuazon E, Skinner D, Raghavan D, Esrig D, Steinberg G, Klotz L, Hall C, Cote R. Cell cycle regulatory protein alterations in a prospective study of patients with organ-confined bladder cancer following radical cystectomy. J Urol 183(4S):e662, 2010. [Citing articles]
  • Mitra AP, Pagliarulo V, Yang D, Groshen S, Cote RJ. A concise 4-gene panel can predict clinical outcome in urinary bladder cancer. J Urol 181(4S):71, 2009.
  • Cote RJ, Mitra AP. Pathology and molecular biology of bladder cancer. Proceedings of the ASCO-ASTRO-SUO Genitourinary Cancers Symposium: 2009 Feb 26-28; Orlando, FL. Alexandria, VA: American Society of Clinical Oncology; 49-50, 2009. ISBN 978-1-932312-70-6
  • Mitra AP, Yang D, Pagliarulo V, Groshen SG, Cote RJ. Generation of a concise gene panel for outcome prediction in urinary bladder cancer. Mol Cancer Ther 6(12 Pt 2):3539S, 2007.
  • Almal AA, Mitra AP, Datar RH, Lenehan PF, Fry DW, Cote RJ, Worzel WP. Using genetic programming to classify node positive patients in bladder cancer. In: Keijzer M, Cattolico M, Arnold D et al (editors). GECCO 2006. Proceedings of the 8th Annual Conference on Genetic and Evolutionary Computation: 2006 Jul 8-12; Seattle, WA. New York: ACM Press; 1: 239-246, 2006. ISBN 1-59593-186-4 [Citing articles]

 

INVITED CONFERENCE POSTERS AND PRESENTATIONS

  • Mitra AP. Securing the future of cancer research funding: The essential role of early-career scientists in advocacy. 103rd AACR Annual Meeting: 2012 Mar 31-Apr 4; Chicago, IL. (Presentation)
  • Mitra AP. Molecular staging of bladder cancer. 21st Annual Meeting of the Italian Society of Uro-Oncology (SIUrO): 2011 Jun 22-24; Naples, Italy. (Presentation)
  • Mitra AP, Birkhahn M, Worzel WP, Groshen S, Cote RJ. Using molecular markers to predict bladder cancer progression. USC Norris Comprehensive Cancer Center – Butch Walts Foundation reception: 2007. (Presentation)
  • Pootrakul L, Mitra AP, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, Lee AS, Cote RJ. Expression of stress response protein GRP78 is associated with the development of castration-resistant prostate cancer. Department of Defense Prostate Cancer Research Program Meeting – IMPaCT: 2007 Sept 5-8; Atlanta, GA. (PosterePosters.net ID# EP10652
  • Mitra AP, George B, Pagliarulo V, Datar RH, Cote RJ. Bladder cancer: Gene expression profiling. USC Norris Comprehensive Cancer Center – Butch Walts Foundation reception: 2004. (Poster)
 
 

NON-PEER-REVIEWED ARTICLES

  • Mitra AP. Urine cytologic analysis: special techniques for bladder cancer detection. In: Kumar GL, Kiernan JA (editors). Connection (vol. 14). Carpinteria, CA: Dako; 2010. p. 169-177. [Citing articles]
  • Mitra AP, Birkhahn M, Cote RJ. Reply from authors re: Joseph L. Chin. In search of the perfect crystal ball for Ta urothelial cancer. Eur Urol 2010;57:21-2. Eur Urol 57(1):23-24, 2010. [PubMed]
  • Mitra AP, Cote RJ. Identifying the nexus between gene and protein in assessment of p53 alterations. In: Kumar GL, Badve S (editors). Connection (vol. 13). Carpinteria, CA: Dako; 2009. p. 12-14.
  • Mitra AP. American Association for Cancer Research - 100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. IDrugs 12(6):339-341, 2009. [PubMed]
  • Mitra AP. American Association for Cancer Research – 100th Annual Meeting (Part IV), Denver, CO, USA. In: Thomson Pharma Partnering, powered by Investigational Drugs database. Philadelphia, PA: Thomson Reuters Scientific. May 6, 2009.
 
 
 
 
 
 
Last Modified: April 2014

© Anirban Mitra 2009-2014